Asset Details
Do you wish to reserve the book?
Neonatal Outcomes after Combined Opioid and Nicotine Exposure in Utero: A Scoping Review
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Neonatal Outcomes after Combined Opioid and Nicotine Exposure in Utero: A Scoping Review
Do you wish to request the book?
Neonatal Outcomes after Combined Opioid and Nicotine Exposure in Utero: A Scoping Review
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Neonatal Outcomes after Combined Opioid and Nicotine Exposure in Utero: A Scoping Review
2021
Overview
Background: The majority of women who are pregnant with opioid use disorder (OUD) also smoke tobacco but are rarely offered tobacco cessation counseling. While the effects of exposure to opioids and nicotine in utero are well-understood separately, understanding the impact of the combined exposure to these substances on neonatal outcomes is lacking. Methods: A scoping review was conducted using PubMed and Scopus databases for studies addressing the combined exposure to opioids and nicotine during pregnancy published between 1 January 1980 and 9 July 2019. A total of 29 papers met the eligibility criteria for inclusion, with nine being identified as clinical trials (three from the MOTHER study) and two as secondary data analysis of clinical trial data. Results: Neonatal outcomes for infants who had a combined exposure to opioids and nicotine in utero indicated a reduction in birth weight and birth length. Findings in infants exposed to both nicotine and opioids were mixed with regard to the duration of neonatal abstinence syndrome (NAS), the likelihood of treatment for NAS, doses of medicine used to treat NAS, and NAS scores when compared with infants who had opioid exposure without nicotine. Conclusions: The combined exposure to nicotine and opioids during pregnancy may lead to a reduction in neonatal birth weight and birth length and more severe NAS signs, compared with opioid use alone, but more research is necessary to identify the minimum dosage and length of nicotine exposure to accurately predict these outcomes.
Publisher
MDPI AG,MDPI
Subject
/ Analgesics, Opioid - adverse effects
/ Citation management software
/ Drug use
/ Female
/ Humans
/ Infant
/ Neonatal abstinence syndrome
/ Neonatal Abstinence Syndrome - drug therapy
/ Neonatal Abstinence Syndrome - epidemiology
/ Nicotine
/ Opioid-Related Disorders - drug therapy
/ Opioid-Related Disorders - epidemiology
/ Review
/ Smoking
/ Tobacco
